Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|16|10|850-863

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.16, Iss.10, 2015-12, pp. : 850-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 Polymorphisms as Risk Factors for Steroid Hormone-Related Cancers

By Friedberg T.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Mechanism and Role of Covalent Heme Binding in the CYP4 Family of P450 Enzymes and the Mammalian Peroxidases

By Ortiz de Montellano Paul  

Drug Metabolism Reviews, Vol. 40, Iss. 3, 2008-07 ,pp. : 405-426

Informa Healthcare

Access to resources Recommend Favorite

The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy

By  

Current Drug Metabolism, Vol. 12, Iss. 8, 2011-10 ,pp. : 713-721

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Polymorphisms of the CYP450 Enzyme Genes on Estrogen Status and the Risk for Osteoporosis

By  

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

The role of pharmacogenetically-variable cytochrome P450 enzymes in

By Howard Lisa A   Sellers Edward M   Tyndale Rachel F  

Pharmacogenomics, Vol. 3, Iss. 2, 2002-03 ,pp. : 185-199

Future Medicine

Access to resources Recommend Favorite